These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30365585)

  • 1. Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review.
    Din RS; Tsiaras WG; Li DG; Mostaghimi A
    J Drugs Dermatol; 2018 Oct; 17(10):1058-1060. PubMed ID: 30365585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
    Handler MZ; Hamilton H; Aires D
    J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Efficacy of Topical Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Case Series.
    Li DG; Din RS; Tsiaras WG; Mostaghimi A
    J Cutan Med Surg; 2018; 22(6):650-651. PubMed ID: 30322308
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials.
    Partridge ACR; Bai JW; Rosen CF; Walsh SR; Gulliver WP; Fleming P
    Br J Dermatol; 2018 Aug; 179(2):290-295. PubMed ID: 29478243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.
    Ciurea AM; Guitart J; Brieva J
    Arch Dermatol; 2010 Jan; 146(1):102-3. PubMed ID: 20083712
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyoderma gangrenosum induced by episiotomy.
    Alani A; Sadlier M; Ramsay B; Ahmad K
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26786531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
    Sakamoto T; Hashimoto T; Furukawa F
    Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behçet's syndrome with pyoderma-gangrenosum-like lesions treated successfully with dapsone monotherapy.
    Joshi A; Mamta
    J Dermatol; 2004 Oct; 31(10):806-10. PubMed ID: 15672708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral pyoderma gangrenosum of the hand: treatment with dapsone.
    Brown RE; Lay L; Graham D
    J Hand Surg Br; 1993 Feb; 18(1):119-21. PubMed ID: 8436847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy.
    Teasley LA; Foster CS; Baltatzis S
    Cornea; 2007 Feb; 26(2):215-9. PubMed ID: 17251816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum of the scalp: pathergic response to herpes zoster infection.
    Alani A; Ahmad K
    Clin Exp Dermatol; 2017 Mar; 42(2):218-219. PubMed ID: 27709657
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature.
    Gade M; Studstrup F; Andersen AK; Hilberg O; Fogh C; Bendstrup E
    Respir Med; 2015 Apr; 109(4):443-50. PubMed ID: 25622759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
    Li J; Kelly R
    J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.
    Kolios AGA; Gübeli A; Meier B; Maul JT; Kündig T; Nilsson J; Hafner J; Guenova E; Kerl K; Anliker M; Kempf W; Navarini AA; French LE; Cozzio A
    Dermatology; 2017; 233(4):268-276. PubMed ID: 29130957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of treatments used in pyoderma gangrenosum.
    Feldman SR; Lacy FA; Huang WW
    Expert Opin Drug Saf; 2018 Jan; 17(1):55-61. PubMed ID: 29065721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum.
    Marzano AV; Trevisan V; Lazzari R; Crosti C
    J Dermatolog Treat; 2010 May; 21(3):140-3. PubMed ID: 19903010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
    Staub J; Pfannschmidt N; Strohal R; Braun-Falco M; Lohse P; Goerdt S; Leverkus M
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2243-7. PubMed ID: 25352307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.